Raymond James & Associates’s KORU Medical Systems KRMD Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2024
Q3
$212K Hold
77,800
﹤0.01% 3614
2024
Q2
$206K Buy
77,800
+52,200
+204% +$119K ﹤0.01% 3587
2024
Q1
$60.4K Buy
+25,600
New +$54.9K ﹤0.01% 3787
2021
Q1
Sell
-16,809
Closed -$101K 4061
2020
Q4
$101K Buy
+16,809
New +$94.1K ﹤0.01% 3555
2020
Q2
Sell
-11,100
Closed -$83K 3603
2020
Q1
$83K Buy
+11,100
New +$74.7K ﹤0.01% 3243

Other funds holding KRMD

Raymond James & Associates's KRMD Position: Q3 2024 in Review

Raymond James & Associates held its KORU Medical Systems (KRMD) position steady in Q3 2024 at 77,800 shares worth $212K. The position accounts for ﹤0.01% of the portfolio, ranked #3614.

Raymond James & Associates first reported a position in KRMD in Q1 2020 and has held it in 5 quarters since. 54 funds tracked by Wall St. Rank hold KRMD as of Q3 2024.

  • Raymond James & Associates held 77,800 shares of KORU Medical Systems worth $212K as of Q3 2024.
  • Raymond James & Associates left its KORU Medical Systems share count unchanged in Q3 2024.
  • KORU Medical Systems made up ﹤0.01% of Raymond James & Associates's portfolio in Q3 2024, its #3614 holding.
  • Raymond James & Associates first reported a position in KORU Medical Systems in Q1 2020 and has held it in 5 quarters since.
  • 54 funds tracked by Wall St. Rank held KORU Medical Systems as of Q3 2024.

Based on Raymond James & Associates's 13F filing for Q3 2024, filed 18 Oct 2024.